Spots Global Cancer Trial Database for tislelizumab combined with chemoradiotherapy
Every month we try and update this database with for tislelizumab combined with chemoradiotherapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Efficacy and Safety of Tislelizumab and Nab-paclitaxel Combined With Low-dose Radiotherapy in Patients With Stage IVb Esophageal Squamous Cell Carcinoma | NCT05547828 | ESCC | Tislelizumab co... | 18 Years - 75 Years | The First Affiliated Hospital of Xinxiang Medical College | |
Efficacy and Safety of Tislelizumab and Nab-paclitaxel Combined With Low-dose Radiotherapy in Patients With Stage IVb Esophageal Squamous Cell Carcinoma | NCT05547828 | ESCC | Tislelizumab co... | 18 Years - 75 Years | The First Affiliated Hospital of Xinxiang Medical College |